ReviewEuropean urology open science2026
Trifecta Outcomes after Robotic Sacrocolpopexy with Dual Mesh in Single-center Cohort.
Review in European urology open science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate anatomical, functional, and safety outcomes of robotic-assisted sacrocolpopexy (RASC) using a novel trifecta endpoint. Methods: Single-center study including 100 consecutive patients undergoing RASC between June 2017 and January 2024 at the University of Foggia. Exclusion criteria were follow-up <12 mo, lack of objective evaluation, and preoperative or occult stress urinary incontinence (SUI) on urodynamics. The trifecta outcome was defined as the simultaneous presence of: a) absence of significant pelvic organ prolapse (POP) recurrence, defined as halfway system (HWS) >1 or POP-Q stage >I at follow-up; b) absence of surgery-requiring de novo SUI; c) absence of postoperative major complications, defined as Clavien-Dindo grade ≥II. Outcomes were assessed at routine visits. Continuous variables are reported as median (IQR) and categorical variables as Results: Median age was 65 yr (IQR 59-70) and body mass index (BMI) 27 kg/m Conclusions: Robotic-assisted sacrocolpopexy with dual meshes provided stable anatomic outcomes with low rates of surgery-requiring de novo SUI and Clavien-Dindo ≥ II complications. The 90% trifecta supports its safety and effectiveness and suggests its utility as a benchmark in prolapse surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.